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	Abstract 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not music 
therapy intervention have an effect on emotional behavior of Alzheimer patients.  Behavior 
variables measuring are agitation and anxiety.  
 
STUDY DESIGN: Systematic review of two randomized, controlled trials published in 2009 
and 2014, respectively, and one randomized control case study published in 2006. 
 
DATA SOURCE: Three published studies comparing music therapy intervention on behavioral 
modifications with Alzheimer patients were found using PubMed and Medline 
 
OUTCOMES MEASURES: All three studies measure behavior in Alzheimer patients based on 
a variety of well validated measures, Behavior Pathology in Alzheimer’s Disease Rating Scale 
(BEHAVE-AD), Cohen-Mansfield Agitation Inventory (CMAI) and the Hamilton Scale. 
 
RESULTS: Svandottir et al showed a significant reduction in anxiety, activity disturbances and 
aggressiveness with music therapy intervention, Guétin et al results confirmed the valuable effect 
that music intervention has on decreasing anxiety in Alzheimer patients and Narme et al study 
showed an improvement in the emotional state of Alzheimer patient. 
 
CONCLUSIONS:  The data show benefit to music therapy as a safe and effective method for 
treating agitation and anxiety in Alzheimer patients. We can conclude that music therapy is 
effective in reducing severity in behavioral mood. Future studies should aim to report data with 
larger sample sizes and with different music genres as variables.  
 
KEY WORDS: Alzheimer Disease, Dementia, Music Therapy  
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INTRODUCTION	
Dementia/Alzheimer Disease (AD) is a progressive chronic deterioration of selective 
functions such as memory loss, cognitive function and motor loss due to loss of brain cells with 
amyloid depositions in the brain.5 This paper evaluates two blinded, randomized controlled trials 
and one case control study comparing the effect on music therapy on the emotional behavior of 
Alzheimer patients. 
In the United States there are currently 5.4 million people diagnosed with Alzheimer's, 
within that number an estimated 5.2 million people are age 65 and older, and 200,000 of the 
diagnoses are under age 65; by the year 2050, it is estimated that in the United States the number 
of people age 65 and older with Alzheimer's disease will triple, from 5.2 million to 13.8 million.5  
Of the top 10 causes of death Alzheimer is the only disease in the list that cannot be cured, 
prevented or even slow the rate of disease progression.5 In 2016, it is estimated to cost the United 
States $236 billion  for healthcare, long term care and hospice for people with diagnosed and 
living with Alzheimer's and other dementias, under half of the costs is covered by Medicare.5 
Nearly one in every five Medicare dollars is spent on people with Alzheimer's and other 
dementias.5 “There is not exact estimate available but studies have shown increase in utilization 
was attributed to AD for inpatient services, pharmacy, ER visits, and home health care AD 
patients were far more likely to be hospitalized for infections, pneumonia and falls” 4 
There is currently no known cure for Alzheimer’s; however certain pharmacologic 
medications have been used to help behavioral function such as SSRI drugs.6  Researchers 
believe that decrease intellectual function are due to organic disease of cerebral hemispheres or 
subcortical structures sufficient enough to interfere with social/occupational function are caused 
by a loss of brain cells with the development of amyloid deposition senile plaques and 
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neurofibrillary tangles (tau proteins) that develop at a faster rate in AD then in normal aging 
process.5,6  
Unfortunately, there is no gold standard treatment for Alzheimer Disease. Treatments to 
help with cognitive and behavioral improvement are pharmacologic drugs such as Ach-esterase 
inhibitors: Donepezil, NMDA antagonist: Memantine, SSRI for depression: Escitalopram. 
Certain nonpharmacological treatments have also been effective in helping with behavioral 
improvement in AD patients such as familiar surroundings and daily routines and musical 
therapy.  
While all the treatment methods mentioned above have been shown to improve 
symptoms in some people with AD, no treatment is effective for everyone. Musical therapy may 
be an effective alternative with behavioral modifications in reducing anxiety and agitation in AD 
patients.  
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not music therapy 
intervention have an effect on emotional behavior of Alzheimer patients. 
METHODS 
This review focused on patients that have been diagnosed with Alzheimer disease. The 
intervention studied was music therapy as behavioral treatment. Svansdottir et al. studied music 
therapy group against controlled group with no music intervention; the therapy group received 
18 sessions of music therapy, each lasting 30 minutes, three times a week for 6 weeks but the 
control group had no change of care.3 . Guétin et al. compared two groups of Alzheimer patients 
comparing a music therapy group with a controlled group without music therapy; the duration of 
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follow-up was 24 weeks between two Alzheimer groups the treated group participated in weekly 
sessions of individual, receptive music therapy. The principal endpoint, measured at weeks 1, 4, 
8, 16 and 24.2  Narme et al compared a cooking therapy group and music therapy group with 
patients with moderate to severe dementia. The interventions took place for a duration of one 
hour, twice a week, for a period of 4 weeks (total 8 hours).1 Though many outcomes were 
evaluated in each study, the outcome of focus for the review was a reduction in behavioral 
function of anxiety and agitation in Alzheimer patients when using music therapy. Two of the 
studies were randomized control trials (RCT) and one of the studies was a case control RCT 
study. Each article was published in a peer-reviewed journal and all articles were published in 
English. Databases accessed included PubMed and Medline and searches were done with the 
keywords “Alzheimer Disease,” “Dementia” and “Music therapy”. Articles were selected by the 
author based on relevance and inclusion of patient oriented outcomes (POEMS). Inclusion 
criteria included recent studies that were RCTs or case control studies and patients diagnosed 
with AD. Exclusion criteria included patients with other neurological disorders. Statistical data 
analysis was reported using p-value, standard deviation, mean and ANOVA. Table 1 displays the 
demographics and characteristics of these studies. 
Table 1: Demographics and Characteristics of Included Studies  
Study Type # Pts Age 
(yrs) 
Inclusion criteria Exclusion 
Criteria 
W/D Interventions 
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Narme, 
2014 
(1) 
RCT 48  N/A Native French speaking 
patients that met the 
diagnostic criteria for 
dementia of the 
Alzheimer’s type or 
mixed dementia 
according to the DSM-
IV. Used Mini-Mental 
State Examination 
(MMSE), and only 
participants with a 
score equal to or below 
20  
Participants with 
a high musical 
expertise, as 
assessed by the 
Musical 
Experience 
Questionnaire 
were excluded 
23% 
lost 
The interventions 
took place for a 
duration of one hour, 
twice a week, for a 
period of 4 weeks 
(total 8 hours). 
During the music 
sessions, music was 
played on a CD 
player. The excerpts 
covered different 
styles of music 
Guétin, 
2009 
(2) 
RCT 30 70-95 Mild to moderate stages 
of AD. Each patient 
was required to have a 
baseline Mini Mental 
State Evaluation 
(MMSE) score of 
between 12 and 25 and 
Hamilton Anxiety Scale 
score of 12. 
Life-threatening 
illness during 
the envisaged 
study period 
were not 
included in the 
study. Likewise, 
patients with 
other 
neurological 
disorders 
N/A The duration of 
follow-up was 24 
weeks between two 
AD groups control 
versus music therapy. 
The treated group 
participated in 
weekly sessions of 
individual, receptive 
music therapy.  
Svansdottir, 
2006 
(3) 
RCT 47 71-87 patients had been 
diagnosed with AD 
using ICD-10 and had 
moderate or severe 
dementia according to 
stages 5–7 on the 
Global Deterioration 
Scale. 
 
Patients with 
other types of 
dementia. 
 
20% 
loss 
The therapy group 
received 18 sessions 
of music therapy, 
each lasting 30 
minutes, 3 times a 
wks for 6 wks but the 
control group had no 
change of care. 
 
OUTCOMES MEASURED 
Changes in behavioral function in Alzheimer patients when using music therapy addressing the 
outcomes of anxiety and agitation were measured using Behavior Pathology in Alzheimer’s 
Disease Rating Scale (BEHAVE-AD) scoring 7 different emotional behaviors. Limited 
information on how BEHAVE-AD is scored;3 The Hamilton Scale, with the total score ranging 
from 0 to 56. This scale consists of 14 items covering all of the sectors of psychosomatic 
anxiety;2 and Cohen-Mansfield Agitation Inventory (CMAI) to rate agitated behavior and their 
frequency.1 Preliminary analyses were conducted using the Mann-Whitney U test to verify that 
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both groups (music and cooking) were well matched at baseline measures in terms of 
demographic characteristics, cognitive and behavioral status. To determine who responded to 
treatment, Spearman’s non-parametric correlations were conducted between benefits observed 
during intervention and patients’ characteristics.1 
 RESULTS 
Results from each study were presented as continuous data that could not be converted to 
dichotomous data; therefore, relative risk reduction (RRR), absolute risk reduction (ARR), or 
numbers needed to treat (NNT) were not calculated for this review. Notably, no adverse effects 
or harm to patients secondary to treatment were reported in any of the studies. Patients were 
recruited by Svansdottir et al. from two nursing homes and two psychogeriatric wards totally 47 
patients in the age range 71-87 years. At the time of the trial all of these patients had been 
diagnosed with AD according to ICD-10 and had moderate or severe dementia according to 
stages 5–7 on the Global Deterioration Scale.3 Guétin et al. recruited patients were required to 
have a baseline Mini Mental State Evaluation (MMSE) score of between 12 and 25 and a 
baseline Hamilton Anxiety Scale score of at least 12. The included patients were men or women 
aged 70–95 years, with adequate verbal or written expression, visual and hearing abilities 
(hearing aids not permitted) in order to carry out the tests. All of the patients had been receiving 
stable anticholinergic treatment for 6 months.2 Narme et al recruited a total of 48 participants 
were recruited at the Wilson nursing home in Reims University Hospital. They met the 
diagnostic criteria for dementia of the Alzheimer’s type or mixed dementia according to the 
DSM-IV.1 The severity of dementia was assessed by the Mini-Mental State Examination 
(MMSE), and only participants with a score equal to or below 20 (moderate or severe stages) 
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were included. Only native French speakers were recruited in order to ensure familiarity with the 
songs selected for music sessions.1 
The study conducted by Svansdottir et al consisted of 38 participants with moderate or 
severe Alzheimer’s disease (AD) assigned randomly to a music therapy group and a control 
group. The control group n=18 participants and music therapy group n=20 participants during a 
6-week period were measured with the Behavior Pathology in Alzheimer’s Disease Rating Scale 
(BEHAVE-AD). Analysis was sum of scores of activity for disturbances, aggressiveness and 
anxiety. For participants that did not complete the whole intervention few data are available; the 
dropout rate was significant as eight patients (17.4%) moved from the psychogeriatric ward to a 
nursing home (n=5), deteriorated (n=2) or died (n=1). Thus 38 patients were able to participate in 
all of the sessions.3 
To analyze their data Svansdottir et al used change in mean from baseline. Music 
Therapy group Aggressiveness mean from baseline; before treatment mean 0.7, after treatment 
1.2 and four weeks post treatment 1.1. The mean change from baseline for Control group no 
music therapy before treatment 1.3, after treatment 1.3 and post treatment 4 weeks 0.8. Music 
Therapy group Affective disturbance before treatment mean 0.3, after treatment 0.6 and four 
weeks post treatment 0.5.  Control group no music therapy mean before treatment 0.5, after 
treatment 0.4 and post treatment 4 weeks 0.1. Music Therapy group Anxieties and Phobias mean 
before treatment 1.0, after treatment 0.7 and four weeks post treatment 0.8. Control group no 
music therapy mean before treatment 0.2, after treatment 0.4 and post treatment 4 weeks 0.3. 
When three of the seven categories of the BEHAVE-AD (activity disturbances, aggressiveness 
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and anxiety) were put together, there was a significant reduction in symptoms in the therapy 
group (p <0.01) but not in the control group (p = 0.5). Table 2 summarizes these results. 
Table 2: Comparison of pre and post Music intervention on Behavior (Svansdottir et al3) 
 Therapy Group Control Group 
Before tx After tx 4 post tx Before tx After tx 4 post tx 
Aggressiveness 0.7 1.2 1.1 1.3 1.3 0.8 
Affective disturbance 0.3 0.6 0.5 0.5 0.4 0.1 
Anxieties/Phobias 1.0 0.7 0.8 0.2 0.4 0.3 
 
Narme et al conducted a study consisting of 48 patients analyzing agitated behaviors and 
their frequency were rated using the CMAI, with higher scores corresponding to greater 
occurrence of agitated behaviors (total score out of 203). The NPI is a brief interview filled out 
by professional caregivers, which examines the frequency and severity of several domains of 
behavioral functioning (e.g., delusions, hallucinations, agitation/aggression, disinhibition, sleep 
abnormalities). For this study we analyzed the agitation/aggression behavior variable. For 
participants that did not complete the whole intervention few data are available.  
To analyze their data, Narme et al used mean change from baseline and standard 
deviation as the variables measured. Behavioral functioning (agitated behaviors) Music therapy 
group Baseline BL-1= -, BL-0 =41.4 ±12.9; Music therapy intervention group 1MID= 33.1 ± 
10.6, 1END= 37.5 ± 16.4; Music therapy after intervention group POST+2= 35.2 ± 9.2, 
POST+4=40.2 ±15.4. There was no significant difference at IEND p=0.1, POST+2 p=0.06 and 
POST+4 p=0.4 Cooking therapy Baseline group BL-1= -, BL-0= 41.6 ±15.2; Cooking therapy 
intervention group 1MID= 34 ± 9.1, 1END= 31.8 ± 5.6; Cooking therapy after intervention 
group POST+2= 34.9 ± 9.6, POST+4=34 ±7.6. There was a decrease in agitated behavior for all 
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evaluations, IMID p=.005, IEND p=0.001, POST+2 p=0.003, and POST+4 p=0.007. Table 3 
summarizes these results. 
Table 3: Comparison of pre and post Music intervention on Agitation (Narme et al1) 
Agitation Baseline During Intervention After Intervention 
 BL-1 BL0 I MID I END POST + 2 Post +4 
Music - 41.4 ± 12.9 33.1 ± 10.6 37.5 ± 16.4 35.2 ± 9.2 40.2 ± 15.4 
Cooking - 41.6 ± 15.2 34 ± 9.1 31.8 ± 5.6 34.9 ± 9.6 34 ± 7.6 
 
The final study conducted by Guétin	et	al	was	a single-centre, comparative, controlled, 
randomized study, with blinded assessment of its results. Follow-up was 24 weeks in the study. 
The treated group (n = 15) participated in weekly sessions of individual, receptive music therapy; 
while control group (n = 15) participated under the same conditions in reading sessions. The 
Level of anxiety (Hamilton Scale) measured at 1, 4, 8, 16 and 24 weeks for endpoint results. 
To analyze data Guétin	et	al	used	ANOVA with repeated measures (D0, W4, W8 and 
W16) showed a significant difference (p<0.0001); the between D0 and W16 groups progressed 
in a different manner during follow-up. At D0, level of anxiety was comparable between the 2 
groups: 22 (±	5.3) for the music therapy group and 21.1 (±5 .6) for the control group. At W16 for 
music therapy a further decrease, 8.4 (±	3.7) versus 20.8 (±	6.2) for the control group. The 
changes between D0 and W16 were significantly different between the 2 groups as regards this 
endpoint (p< 0.001). After 16 weeks, the improvement corresponded to approximately 13.2 (±	5 
.2) points, in the music therapy group. In the control group, this improvement was in the region 
of 0.9 (±	7.4) points.  ANOVA evidenced a significant difference (p<.0001) at W24; the 
difference between D0 and W24, and also between W16 and W24. A score of 10.6 (±	6 .3) was 
obtained in the music therapy group versus 20.5 (±	5 .4) in the control group at W24. The 
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difference between D0 and W24 appeared to be significant regarding this endpoint (p = 0.002), 
together with the difference between W16 and W24. Table 4 summarizes these results. 
Table 4: Comparison of Anxiety (Guétin et al2) 
Anxiety Music therapy Control 
Value Mean ± SD Mean ± SD  P value 
D0 22.0 ± 5.3 21.1 ± 5.6 Not significant  
W4 15.5 ± 3.7 20.7 ±  4.7 0.002 
W8 12.6 ± 5.2 22.2 ± 4.5 <0.001 
W 16 8.4 ± 3.7 20.8 ± 6.2 <0.001 
W 24 10.6± 6.3 20.5 ± 5.4 <0.001 
D0- W4 -6.5 ± 5.2 -0.4 ± 2.7 <0.001 
W4-W8 -2.9 ± 5.5 0.8 ± 3.9 Not significant  
W8-W16 -4.6± 4.8 -1.4 ± 5.9 Not significant  
D0-16 -13.2 ± 5.2 -0.9 ± 7.4 <0.001 
D0-W24 -11.5 ± 7.2 -1.5 ± 6.8 0.002 
D16-W24 2.1 ± 3.7 -0.8 ± 2.8 0.046 
 
DISCUSSION  
This systematic review demonstrated possible improvement in anxiety and agitation in 
Alzheimer patient’s by using music therapy intervention in place of or in addition to standard 
Alzheimer treatment therapies. The three studies showed improvement in anxiety and agitation; 
however, the limitations of these studies raises questions about the true efficacy of music therapy 
as an intervention for relief of certain behavioral modifications in Alzheimer disease.  
A number of limitations existed within the three studies reviewed. Each study consisted of a 
relatively small sample size (each < 50 patients), which could potentially skew the validity of the 
significance of each result.1,2,3 The smallest of the sample sizes came from the study conducted 
by Guétin  et al., which only consisted of 30 individuals. The dropout ratio was also significant 
20% or higher in two of the studies and there was limited data on participants that did not 
complete the studies.1,2  
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In the study Svansdottir et al.  the outcomes are limited because the study showed an effect using 
only one type of music therapy, the active participation of the patient along with the therapist, 
both with instruments and by singing. The study did not compare other types of music therapy 
such as passive listening. There was also no comparison between different types of music 
genres.3 
Limitations in the Narme et al. was the control treatment cooking was used versus a 
“noncontact” group to test the hypothesis that music would have an effect over and above a non-
specific effect due to patient’s stimulation.1 In the study the participants preferences should be 
taken into account in allocating activities to subjects; participants could possibly benefit more 
from the particular kind of intervention they favor.  
In the study Guétin et al. it was suggested that further studies focusing on neurobiological using 
electrophysiological, positron emission tomography, functional MRI or morphological cerebral 
MRI studies will give a better understanding into the physiological mechanisms used during this 
type of non-medicinal-based therapy.2 
While music therapy may be an effective therapy for behavioral modification in Alzheimer 
patients, particularly in combination with other therapies, access may be problematic for patients. 
Music therapy is not covered by a patient’s insurance, so regular music therapy sessions may 
place additional financial strain on patients. Lastly, not all nursing home facilities offer music 
therapy. The studies did not evaluate if home practice alone, without the assistance of a therapist, 
would be beneficial in reducing Alzheimer patient’s anxiety and agitation.  
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CONCLUSION  
The studies reviewed in order to answer the question “does music therapy intervention 
have an effect on the emotional behavior of Alzheimer patients” show evidence in support of the 
hypothesis. Results of the three studies show benefit to music therapy as a safe and effective 
method for treating agitation and anxiety in Alzheimer patients. We can conclude that music 
therapy is effective in reducing severity in behavioral mood. Music therapy is a low-risk 
treatment option that may prove to be beneficial to those dealing with this incurable disease. 
Future studies are necessary before routinely recommending music therapy as an effective 
treatment for reducing symptoms of anxiety and agitation in Alzheimer disease. Future studies 
should include a sample size large enough to generalize findings and data on drop outs of 
participants. It is also essential to study the effects of different genres of music as well as giving 
participants there choice on music category. Finally, the studies should use neuroimaging such as 
MRI or PET to look on the brain during these interventions. 
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